Personalized Medicine and Epigenomics: Technologies and Global Markets
NEW YORK, March 21, 2016 /PRNewswire/ -- This BCC Research report discusses the global epigenomic market in terms of growth, size and opportunities with regard to different therapies, technologies, as well as regionally. The report includes forecasted trends and revenue through 2020.
Use this report to:
Gain insight into the global market for epigenomics, including emerging opportunities in biomarkers, diagnostics and therapeutics.
Assess global epigenomic market by types, application areas, products, segments, and regions.
Identify market trends, issues and factors impacting the epigenomic market.
Highlights
The global epigenomic market reached nearly $4 billion in 2014 and $4.7 billion in 2015. The market should reach nearly $12.1 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 20.6% from 2015 to 2020.
North America dominated the global epigenomic market and reached $1.9 billion in 2015.
The market should reach $4.6 billion in 2020 at a CAGR of 19.9% from 2015 to 2020.
The Asia-Pacific epigenomic market reached nearly $1.0 billion in 2015, and should reach $2.8 billion by 2020 growing at a CAGR of 22.8% throughout the period.
INTRODUCTION
The report Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics discusses the global epigenomic market in terms of growth, size and opportunities with regard to different therapies, technologies, as well as regionally. The report includes forecasted trends and revenue through 2020. Major players, innovative products and technologies, trends and market dynamics, competitive intelligence and
regional trends are well-researched and analyzed.
STUDY GOALS AND OBJECTIVE
Define and discuss the global market for epigenomics, including emerging opportunities in biomarkers, diagnostics and therapeutics.
Analyze market structure by segments and subsegments.
Estimate market revenues by regions and products.
Identify market trends, issues and factors impacting the epigenomic market.
Explain opportunities with respect to regions and products.
Profile major players and analyze their core competencies and strategies.
Track alliances, joint ventures, mergers and acquisitions, new product developments, and research and development.
TITLE DESCRIPTION
The term epigenetics refers to the study of alterations in genes that are not facilitated by any change in DNA sequence. Epigenetics is essential for the development of mammals due to its benefits and threats. Epigenetic regulation is a key factor for the development of mammals and cellular differentiation. On the contrary, epigenetic dysregulation results in diseases, including cancer and various other genetic disorders.
The human genome consists of DNA, which is responsible for encoding genetic information. Epigenomes include histone and DNA modification layered on top of the genome. These are responsible for directing the genome to feed information to genes during particular events. The epigenetic condition of a cell is affected by both developmental and environmental factors, including nutrition, toxins, infection and drugs of abuse. Thus, epigenetics exhibits a close relationship between environment and genome.
The study of epigenetics has evolved over the years, leading to rapid changes on the technological front. Epigenetic study using DNA sequencing technology has enabled researchers to perform large-scale experiments as compared to micro-array approaches. Constant evolution in technology, including the adoption of more advanced sequencing techniques, is expected to assist researchers to perform experiments at supreme resolutions.
SCOPE OF THE REPORT
The report will analyze the market by types, products and applications. It will also focus on emerging technologies and therapies. Geographically, the market is divided into five regions: North America, Europe, the Asia-Pacific region and Latin America, and the Middle East and Asia (MEA).
Products are segmented by reagents, kits, instruments, enzymes and services.
Technologies are segmented by DNA methylation, histone methylation and acetylation, MicroRNA modification.
Applications are segmented areas by diagnosis, prognosis, therapy optimization in routine clinical treatment and drug discovery.
Therapy areas are segmented by cancer treatment, neurological disorders, CVD and others, which includes the research and development (R&D) stage.
Cancer treatment is further broken down into hematological cancers, solid tumors, gastric cancer, lung cancer and others.
Read the full report: http://www.reportlinker.com/p03703405-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article